VRTX Vertex Pharmaceuticals Incorporated
Healthcare$436.81+0.00%OpenMarket Cap: $110.86B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$552.80
Target (Median)
$558.00
Target Range
$436.00 - $616.00
Upside from current price: 26.6%
Rating Distribution
6 Strong Buy21 Buy5 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Barclays | maintain | Overweight | Overweight |
| 2026-05-05 | Canaccord Genuity | maintain | Hold | Hold |
| 2026-05-05 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-05 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-05 | Bernstein | maintain | Outperform | Outperform |
| 2026-03-18 | Maxim Group | upgrade | Buy | Hold |
| 2026-03-11 | Truist Securities | maintain | Buy | Buy |
| 2026-03-10 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-10 | B of A Securities | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $21.61 | $14.27B | 19 |
| Sun Dec 31 | $25.03 | $15.84B | 13 |
| Mon Dec 31 | $28.89 | $17.60B | 11 |
| Tue Dec 31 | $33.33 | $19.44B | 5 |